Troy J Plumb1, Luis Alvarez2, Dennis L Ross3, Joseph J Lee4, Jeffrey G Mulhern5, Jeffrey L Bell6, Graham E Abra7, Sarah S Prichard8, Glenn M Chertow9, Michael A Aragon10. 1. University of Nebraska, Nebraska Medical Center, Omaha, Nebraska, 68198, USA. 2. Palo Alto Medical Foundation, 795 El Camino Real, Palo Alto, California, 94301, USA. 3. Kansas Nephrology Research Institute, 1007 N. Emporia, Wichita, Kansas, 67214, USA. 4. Nephrology Associates Medical Group, 3660 Park Sierra #208, Riverside, California, 92505, USA. 5. Fresenius Kidney Care Pioneer Valley Dialysis, 208 Ashley Ave, West Springfield, Massachusetts, 01089, USA. 6. Southwest Georgia Nephrology Clinic, 1200 North Jefferson Street, Albany, Georgia, 31701, USA. 7. Stanford University, 300 Pasteur Drive, 1st floor, Suite A175, Stanford, California, 94305, USA. 8. Western University, London, Ontario, Canada. 9. Stanford University School of Medicine, 1070 Arastradero Road, Palo Alto, California, 94034, USA. 10. DaVita Grapevine at Home, 1600 W. Northwest Hwy, Suite 100, Grapevine, Texas, 76051, USA.
Abstract
INTRODUCTION: Recently published results of the investigational device exemption (IDE) trial using the Tablo hemodialysis system confirmed its safety and efficacy for home dialysis. This manuscript reports additional data from the Tablo IDE study on the training time required to be competent in self-care, the degree of dependence on health care workers and caregivers after training was complete, and participants' assessment of the ease-of-use of Tablo. METHODS: We collected data on the time required to set up concentrates and the Tablo cartridge prior to treatment initiation. We asked participants to rate system setup, treatment, and takedown on a Likert scale from 1 (very difficult) to 5 (very simple) and if they had required any assistance with any aspect of treatment over the prior 7 days. In a subgroup of 15 participants, we recorded the number of training sessions required to be deemed competent to do self-care dialysis. FINDINGS: Eighteen men and 10 women with a mean age of 52.6 years completed the study. Thirteen had previous self-care experience using a different dialysis system. Mean set up times for the concentrates and cartridge were 1.1 and 10.0 minutes, respectively. Participants with or without previous self-care experience had similar set-up times. The mean ease-of-use score was 4.5 or higher on a scale from 1 to 5 during the in-home phase. Sixty-five percent required no assistance at home and on average required fewer than four training sessions to be competent in managing their treatments. Results were similar for participants with or without previous self-care experience. CONCLUSIONS: Participants in the Tablo IDE trial were able to quickly learn and manage hemodialysis treatments in the home, found Tablo easy to use, and were generally independent in performing hemodialysis.
INTRODUCTION: Recently published results of the investigational device exemption (IDE) trial using the Tablo hemodialysis system confirmed its safety and efficacy for home dialysis. This manuscript reports additional data from the Tablo IDE study on the training time required to be competent in self-care, the degree of dependence on health care workers and caregivers after training was complete, and participants' assessment of the ease-of-use of Tablo. METHODS: We collected data on the time required to set up concentrates and the Tablo cartridge prior to treatment initiation. We asked participants to rate system setup, treatment, and takedown on a Likert scale from 1 (very difficult) to 5 (very simple) and if they had required any assistance with any aspect of treatment over the prior 7 days. In a subgroup of 15 participants, we recorded the number of training sessions required to be deemed competent to do self-care dialysis. FINDINGS: Eighteen men and 10 women with a mean age of 52.6 years completed the study. Thirteen had previous self-care experience using a different dialysis system. Mean set up times for the concentrates and cartridge were 1.1 and 10.0 minutes, respectively. Participants with or without previous self-care experience had similar set-up times. The mean ease-of-use score was 4.5 or higher on a scale from 1 to 5 during the in-home phase. Sixty-five percent required no assistance at home and on average required fewer than four training sessions to be competent in managing their treatments. Results were similar for participants with or without previous self-care experience. CONCLUSIONS:Participants in the Tablo IDE trial were able to quickly learn and manage hemodialysis treatments in the home, found Tablo easy to use, and were generally independent in performing hemodialysis.
Authors: Eric D Weinhandl; Jiannong Liu; David T Gilbertson; Thomas J Arneson; Allan J Collins Journal: J Am Soc Nephrol Date: 2012-02-23 Impact factor: 10.121
Authors: Julia V Marley; Hannah K Dent; Maree Wearne; Cherelle Fitzclarence; Carmel Nelson; Karen Siu; Kevin Warr; David Atkinson Journal: Med J Aust Date: 2010-11-01 Impact factor: 7.738
Authors: Bessie A Young; Christopher Chan; Christopher Blagg; Robert Lockridge; Thomas Golper; Fred Finkelstein; Rachel Shaffer; Rajnish Mehrotra Journal: Clin J Am Soc Nephrol Date: 2012-10-04 Impact factor: 8.237
Authors: Mark R Marshall; Nora van der Schrieck; David Lilley; Sharen K Supershad; Alvin Ng; Rachael C Walker; Joanna L Dunlop Journal: Am J Kidney Dis Date: 2012-12-07 Impact factor: 8.860
Authors: Mark R Marshall; Kevan R Polkinghorne; Peter G Kerr; Carmel M Hawley; John W M Agar; Stephen P McDonald Journal: Am J Kidney Dis Date: 2015-11-11 Impact factor: 8.860
Authors: Joseph A Cafazzo; Kevin Leonard; Anthony C Easty; Peter G Rossos; Christopher T Chan Journal: Clin J Am Soc Nephrol Date: 2009-04-01 Impact factor: 8.237
Authors: Troy J Plumb; Luis Alvarez; Dennis L Ross; Joseph J Lee; Jeffrey G Mulhern; Jeffrey L Bell; Graham Abra; Sarah S Prichard; Glenn M Chertow; Michael A Aragon Journal: Hemodial Int Date: 2019-11-07 Impact factor: 1.812